Farooq F, Sultana S, Alqahtani N, Imran M
PLoS One. 2025; 20(1):e0316617.
PMID: 39823527
PMC: 11741607.
DOI: 10.1371/journal.pone.0316617.
Zareie A, Dabral P, Verma S
Pathogens. 2024; 13(1).
PMID: 38251367
PMC: 10819198.
DOI: 10.3390/pathogens13010060.
Wang S, Li H, Lian Z, Deng S
Int J Mol Sci. 2022; 23(14).
PMID: 35886919
PMC: 9317671.
DOI: 10.3390/ijms23147571.
Freen-van Heeren J
BioTech (Basel). 2022; 10(4).
PMID: 35822795
PMC: 9245478.
DOI: 10.3390/biotech10040021.
Kone B, Sarro Y, Baya B, Dabitao D, Coulibaly N, Wague M
Infect Dis Diagn Treat. 2021; 3(1).
PMID: 34355138
PMC: 8336946.
Clinical therapeutic effects of topical agents in adult patients with human immunodeficiency virus-related oral mucosa ulcers: A protocol for systematic review and meta-analysis.
Ding X, Xu F, Zhang X
Medicine (Baltimore). 2021; 100(6):e23626.
PMID: 33578511
PMC: 7886410.
DOI: 10.1097/MD.0000000000023626.
Smart materials-integrated sensor technologies for COVID-19 diagnosis.
Erdem O, Derin E, Sagdic K, Yilmaz E, Inci F
Emergent Mater. 2021; 4(1):169-185.
PMID: 33495747
PMC: 7817967.
DOI: 10.1007/s42247-020-00150-w.
Current and historic HIV-1 molecular epidemiology in paediatric and adult population from Kinshasa in the Democratic Republic of Congo.
Rubio-Garrido M, Gonzalez-Alba J, Reina G, Ndarabu A, Barquin D, Carlos S
Sci Rep. 2020; 10(1):18461.
PMID: 33116151
PMC: 7595211.
DOI: 10.1038/s41598-020-74558-z.
Recent Advances in the Development of Integrase Inhibitors for HIV Treatment.
Trivedi J, Mahajan D, Jaffe R, Acharya A, Mitra D, Byrareddy S
Curr HIV/AIDS Rep. 2020; 17(1):63-75.
PMID: 31965427
PMC: 7004278.
DOI: 10.1007/s11904-019-00480-3.
Prevalence and route of transmission of undiagnosed human immunodeficiency virus infection among children using provider-initiated testing and counselling strategy in Ido-Ekiti, Nigeria: a cross-sectional study.
Babatunde O, Babatunde L, Oladeji S
Pan Afr Med J. 2019; 34:62.
PMID: 31803344
PMC: 6876896.
DOI: 10.11604/pamj.2019.34.62.9374.
HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus.
Iwase S, Miyazato P, Katsuya H, Islam S, Yang B, Ito J
Sci Rep. 2019; 9(1):12326.
PMID: 31444406
PMC: 6707141.
DOI: 10.1038/s41598-019-48681-5.
Problems with precaution: the transfusion medicine experience.
Wilson K, Atkinson K, Fergusson D, Brown A, Forster A, Murphy M
J Risk Res. 2018; 22(2):137-49.
PMID: 29348731
PMC: 5770215.
DOI: 10.1080/13669877.2017.1351478.
Re-emerging and newly recognized sexually transmitted infections: Can prior experiences shed light on future identification and control?.
Bernstein K, Bowen V, Kim C, Counotte M, Kirkcaldy R, Kara E
PLoS Med. 2017; 14(12):e1002474.
PMID: 29281630
PMC: 5744912.
DOI: 10.1371/journal.pmed.1002474.
Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics.
Holec A, Mandal S, Prathipati P, Destache C
Curr HIV Res. 2017; 15(6):411-421.
PMID: 29165087
PMC: 7219633.
DOI: 10.2174/1570162X15666171120110145.
Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese.
He L, Zhao J, Wang M, Siu K, Gan Y, Chen L
PLoS One. 2014; 9(5):e96792.
PMID: 24816922
PMC: 4016030.
DOI: 10.1371/journal.pone.0096792.
In vitro and in vivo activities of AIC292, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.
Wildum S, Paulsen D, Thede K, Ruebsamen-Schaeff H, Zimmermann H
Antimicrob Agents Chemother. 2013; 57(11):5320-9.
PMID: 23959304
PMC: 3811302.
DOI: 10.1128/AAC.01377-13.
Antiretroviral drug resistance in human immunodeficiency virus type 2.
Ntemgwa M, Toni T, Brenner B, Camacho R, Wainberg M
Antimicrob Agents Chemother. 2009; 53(9):3611-9.
PMID: 19470514
PMC: 2737883.
DOI: 10.1128/AAC.00154-09.
